OptiNose Historical Financial Ratios

OPTN Stock  USD 0.50  0.01  1.96%   
OptiNose is promptly reporting on over 107 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Invested Capital of 0.0 will help investors to properly organize and evaluate OptiNose financial condition quickly.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.

About OptiNose Financial Ratios Analysis

OptiNoseFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate OptiNose investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on OptiNose financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across OptiNose history.

OptiNose Financial Ratios Chart

At this time, OptiNose's Payables Turnover is very stable compared to the past year. As of the 11th of December 2024, Income Quality is likely to grow to 0.94, while Price To Sales Ratio is likely to drop 1.93.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing OptiNose stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on OptiNose sales, a figure that is much harder to manipulate than other OptiNose multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is OptiNose dividend as a percentage of OptiNose stock price. OptiNose dividend yield is a measure of OptiNose stock productivity, which can be interpreted as interest rate earned on an OptiNose investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Debt To Equity

A measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets.
Most ratios from OptiNose's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into OptiNose current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.At this time, OptiNose's Payables Turnover is very stable compared to the past year. As of the 11th of December 2024, Income Quality is likely to grow to 0.94, while Price To Sales Ratio is likely to drop 1.93.
 2023 2024 (projected)
Dividend Yield0.05180.0461
Price To Sales Ratio2.041.93

OptiNose fundamentals Correlations

0.3-0.11.0-0.360.550.09-0.21-0.11.00.10.9-0.640.20.76-0.650.99-0.35-0.77-0.7-0.310.32-0.770.760.680.35
0.3-0.140.310.14-0.1-0.390.13-0.140.3-0.380.33-0.26-0.320.43-0.680.340.16-0.03-0.38-0.820.15-0.030.410.28-0.1
-0.1-0.14-0.070.17-0.48-0.640.01.0-0.1-0.63-0.510.43-0.6-0.50.41-0.070.19-0.52-0.180.14-0.38-0.52-0.5-0.320.02
1.00.31-0.07-0.360.520.06-0.22-0.071.00.080.89-0.620.180.74-0.640.98-0.35-0.78-0.7-0.320.31-0.780.750.680.35
-0.360.140.17-0.36-0.07-0.70.970.17-0.36-0.73-0.33-0.11-0.80.12-0.18-0.231.00.16-0.4-0.14-0.920.170.1-0.48-0.05
0.55-0.1-0.480.52-0.070.340.1-0.480.550.330.71-0.510.310.68-0.420.55-0.1-0.24-0.40.10.05-0.240.70.220.03
0.09-0.39-0.640.06-0.70.34-0.56-0.640.091.00.31-0.050.980.030.2-0.03-0.710.280.510.40.650.280.060.230.03
-0.210.130.0-0.220.970.1-0.560.0-0.21-0.59-0.12-0.32-0.670.33-0.32-0.080.960.12-0.5-0.13-0.890.130.31-0.370.01
-0.1-0.141.0-0.070.17-0.48-0.640.0-0.1-0.63-0.510.43-0.6-0.50.41-0.070.19-0.52-0.180.14-0.38-0.52-0.5-0.320.02
1.00.3-0.11.0-0.360.550.09-0.21-0.10.10.9-0.640.20.76-0.650.99-0.35-0.77-0.7-0.310.32-0.770.760.680.35
0.1-0.38-0.630.08-0.730.331.0-0.59-0.630.10.31-0.030.990.020.21-0.02-0.730.270.520.390.680.260.050.250.03
0.90.33-0.510.89-0.330.710.31-0.12-0.510.90.31-0.770.380.89-0.770.88-0.32-0.43-0.56-0.340.38-0.430.90.70.21
-0.64-0.260.43-0.62-0.11-0.51-0.05-0.320.43-0.64-0.03-0.77-0.07-0.890.85-0.71-0.110.270.620.370.070.27-0.86-0.56-0.17
0.2-0.32-0.60.18-0.80.310.98-0.67-0.60.20.990.38-0.070.050.150.07-0.810.180.480.330.760.180.080.340.06
0.760.43-0.50.740.120.680.030.33-0.50.760.020.89-0.890.05-0.910.80.12-0.33-0.74-0.44-0.01-0.330.990.530.19
-0.65-0.680.41-0.64-0.18-0.420.2-0.320.41-0.650.21-0.770.850.15-0.91-0.73-0.180.240.690.68-0.010.24-0.87-0.54-0.11
0.990.34-0.070.98-0.230.55-0.03-0.08-0.070.99-0.020.88-0.710.070.8-0.73-0.23-0.78-0.78-0.350.19-0.780.80.640.36
-0.350.160.19-0.351.0-0.1-0.710.960.19-0.35-0.73-0.32-0.11-0.810.12-0.18-0.230.15-0.41-0.16-0.920.150.11-0.47-0.08
-0.77-0.03-0.52-0.780.16-0.240.280.12-0.52-0.770.27-0.430.270.18-0.330.24-0.780.150.710.030.061.0-0.34-0.3-0.45
-0.7-0.38-0.18-0.7-0.4-0.40.51-0.5-0.18-0.70.52-0.560.620.48-0.740.69-0.78-0.410.710.390.420.71-0.74-0.27-0.32
-0.31-0.820.14-0.32-0.140.10.4-0.130.14-0.310.39-0.340.370.33-0.440.68-0.35-0.160.030.39-0.150.03-0.42-0.620.1
0.320.15-0.380.31-0.920.050.65-0.89-0.380.320.680.380.070.76-0.01-0.010.19-0.920.060.42-0.150.050.00.57-0.06
-0.77-0.03-0.52-0.780.17-0.240.280.13-0.52-0.770.26-0.430.270.18-0.330.24-0.780.151.00.710.030.05-0.33-0.3-0.45
0.760.41-0.50.750.10.70.060.31-0.50.760.050.9-0.860.080.99-0.870.80.11-0.34-0.74-0.420.0-0.330.530.19
0.680.28-0.320.68-0.480.220.23-0.37-0.320.680.250.7-0.560.340.53-0.540.64-0.47-0.3-0.27-0.620.57-0.30.530.16
0.35-0.10.020.35-0.050.030.030.010.020.350.030.21-0.170.060.19-0.110.36-0.08-0.45-0.320.1-0.06-0.450.190.16
Click cells to compare fundamentals

OptiNose Account Relationship Matchups

OptiNose fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio11.154.071.232.082.041.93
Ptb Ratio6.2729.44(4.23)(2.81)(1.67)(1.75)
Days Sales Outstanding143.79173.85173.32162.37102.4697.33
Book Value Per Share1.470.14(0.38)(0.66)(0.77)(0.73)
Free Cash Flow Yield(0.38)(0.24)(0.43)(0.84)(0.14)(0.15)
Operating Cash Flow Per Share(2.17)(1.79)(1.35)(0.79)(0.18)(0.19)
Stock Based Compensation To Revenue0.280.210.130.120.07320.0696
Capex To Depreciation0.50.380.260.120.820.78
Pb Ratio6.2729.44(4.23)(2.81)(1.67)(1.75)
Ev To Sales9.053.681.52.572.852.71
Free Cash Flow Per Share(2.18)(1.8)(1.36)(0.79)(0.19)(0.2)
Roic(0.7)(0.65)(0.63)(0.79)(0.52)(0.5)
Inventory Turnover1.520.830.770.981.070.62
Net Income Per Share(2.6)(2.04)(1.44)(0.89)(0.32)(0.33)
Days Of Inventory On Hand240.21438.87472.53372.09340.44323.41
Payables Turnover1.461.371.141.752.222.33
Research And Ddevelopement To Revenue0.60.480.340.20.07470.071
Capex To Revenue0.01610.01110.0022378.26E-40.0046210.00439
Cash Per Share3.512.991.941.10.660.62
Pocfratio(4.25)(2.32)(1.2)(2.35)(7.04)(6.69)
Interest Coverage(9.93)(6.71)(4.16)(3.32)(1.16)(1.22)
Capex To Operating Cash Flow(0.006133)(0.006334)(0.002171)(9.31E-4)(0.016)(0.0168)
Pfcf Ratio(4.23)(2.3)(1.19)(2.35)(6.93)(6.58)
Days Payables Outstanding249.93266.42319.61208.49164.3156.08
Roe(1.77)(14.49)3.751.350.410.43
Ev To Operating Cash Flow(3.45)(2.1)(1.46)(2.89)(9.87)(9.38)
Pe Ratio(3.54)(2.03)(1.13)(2.08)(4.07)(3.87)
Return On Tangible Assets(0.49)(0.63)(0.52)(0.53)(0.33)(0.35)
Ev To Free Cash Flow(3.43)(2.09)(1.46)(2.89)(9.71)(9.23)
Earnings Yield(0.28)(0.49)(0.89)(0.48)(0.25)(0.26)
Net Debt To E B I T D A0.730.22(0.31)(0.64)(3.73)(3.55)
Current Ratio4.072.762.710.530.60.57
Tangible Book Value Per Share1.470.14(0.38)(0.66)(0.77)(0.73)
Receivables Turnover2.542.12.112.253.564.83
Graham Number9.282.543.523.632.352.23
Shareholders Equity Per Share1.470.14(0.38)(0.66)(0.77)(0.73)
Debt To Equity1.2118.44(5.81)(2.27)(1.5)(1.43)
Capex Per Share0.01330.01130.0029377.33E-40.0029260.00278
Graham Net Net1.15(0.33)(0.79)(0.89)(0.91)(0.86)

Pair Trading with OptiNose

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OptiNose position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OptiNose will appreciate offsetting losses from the drop in the long position's value.

Moving together with OptiNose Stock

  0.84JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.8LLY Eli LillyPairCorr

Moving against OptiNose Stock

  0.82BMY Bristol Myers SquibbPairCorr
  0.68CAH Cardinal HealthPairCorr
  0.59ESPR Esperion TherapeuticsPairCorr
  0.59XAIR Beyond AirPairCorr
  0.53GILD Gilead SciencesPairCorr
The ability to find closely correlated positions to OptiNose could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OptiNose when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OptiNose - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OptiNose to buy it.
The correlation of OptiNose is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OptiNose moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OptiNose moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OptiNose can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether OptiNose offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OptiNose's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Optinose Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Optinose Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OptiNose. If investors know OptiNose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OptiNose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.29)
Revenue Per Share
0.553
Quarterly Revenue Growth
0.031
Return On Assets
(0.10)
Return On Equity
(10.51)
The market value of OptiNose is measured differently than its book value, which is the value of OptiNose that is recorded on the company's balance sheet. Investors also form their own opinion of OptiNose's value that differs from its market value or its book value, called intrinsic value, which is OptiNose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OptiNose's market value can be influenced by many factors that don't directly affect OptiNose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.